Advanced

Biomarkers of early chronic obstructive pulmonary disease (COPD) in smokers and former smokers. Protocol of a longitudinal study.

Truedsson, Mikael; Malm, Johan LU ; Sahlin, Barbara LU ; Bugge, May; Wieslander, Elisabet LU ; Dahlbäck, Magnus LU ; Appelqvist, Roger LU ; Fehniger, Thomas LU and Marko-Varga, György LU (2016) In Clinical and Translational Medicine 5(1).
Abstract
Chronic obstructive pulmonary disease (COPD) is an irreversible disease, diagnosed predominantly in smokers. COPD is currently the third leading cause of death worldwide. Far more than 15 % of smokers get COPD: in fact, most develop some amount of pulmonary impairment. Smoking-related COPD is associated with both acute exacerbations and is closely correlated to comorbidities, such as cardiovascular disease and lung cancer. The objective of our study (KOL-Örestad) is to identify biomarkers in smokers and ex-smokers, with early signs of COPD, and compare these biomarkers with those of non-smokers and healthy smokers/ex-smokers. The participants in the study are recruited from Örestadskliniken, a primary health care clinic in Malmö, Sweden.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Clinical and Translational Medicine
volume
5
issue
1
publisher
Springer
external identifiers
  • PMID:26951192
ISSN
2001-1326
DOI
10.1186/s40169-016-0086-5
language
English
LU publication?
yes
id
590a7cf4-8810-4be1-9fba-557e9ed1b1ff (old id 8853122)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26951192?dopt=Abstract
date added to LUP
2016-03-16 15:04:04
date last changed
2016-09-20 03:05:41
@misc{590a7cf4-8810-4be1-9fba-557e9ed1b1ff,
  abstract     = {Chronic obstructive pulmonary disease (COPD) is an irreversible disease, diagnosed predominantly in smokers. COPD is currently the third leading cause of death worldwide. Far more than 15 % of smokers get COPD: in fact, most develop some amount of pulmonary impairment. Smoking-related COPD is associated with both acute exacerbations and is closely correlated to comorbidities, such as cardiovascular disease and lung cancer. The objective of our study (KOL-Örestad) is to identify biomarkers in smokers and ex-smokers, with early signs of COPD, and compare these biomarkers with those of non-smokers and healthy smokers/ex-smokers. The participants in the study are recruited from Örestadskliniken, a primary health care clinic in Malmö, Sweden.},
  author       = {Truedsson, Mikael and Malm, Johan and Sahlin, Barbara and Bugge, May and Wieslander, Elisabet and Dahlbäck, Magnus and Appelqvist, Roger and Fehniger, Thomas and Marko-Varga, György},
  issn         = {2001-1326},
  language     = {eng},
  number       = {1},
  publisher    = {ARRAY(0x3c867c0)},
  series       = {Clinical and Translational Medicine},
  title        = {Biomarkers of early chronic obstructive pulmonary disease (COPD) in smokers and former smokers. Protocol of a longitudinal study.},
  url          = {http://dx.doi.org/10.1186/s40169-016-0086-5},
  volume       = {5},
  year         = {2016},
}